The Future of Cancer Treatment is Here!
What is So Special about the Universal Cancer Vaccine Platform?
You may wonder why, with all the money invested in research, cancer still doesn’t have a cure.
The simple answer can be found in the fact that cancer isn’t just one disease but a collection of more than 100 diseases that may have many different characteristics, risk factors, causes and treatments.
One single treatment for all types of cancer is not likely to successfully treat all cancers. Potentially, dozens of treatments —even hundreds of treatments are needed.
Working with a world class team of experienced cancer researchers and physicians, the CancerVax team asked the question, “What if we could create a universal cancer vaccine platform that could be used to treat many different types of cancer”?
Thus, the Universal Cancer Vaccine platform (UCV) was born, which uses the body’s immune system to fight cancer. It is designed to be customizable, administered as a shot, and leverage state-of-the-art bioengineering and molecular technologies.
This innovative approach detects, marks, and kills cancer cells exclusively. By inducing cancer cells to express a distinct marker absent in healthy cells, custom antibody drugs and the body's immune cells can precisely target and eradicate cancer cells.
When people hear the word vaccine, they often think of traditional vaccines that stimulate an immune response to prevent the development of disease like covid, polio, or smallpox.
But there are entirely different types of vaccines, immunotherapy treatment vaccines that are used after a condition or disease has developed and act as a form of therapy.
While not preventative, there are vaccines that treat existing cancer, called treatment vaccines or therapeutic vaccines. These vaccines are a type of cancer treatment called immunotherapy. They work to boost the body's immune system to fight cancer.
The future of cancer treatment is with this type of treatment and CancerVax is working with UCLA to be at the forefront of it.
Our Universal Cancer Vaccine platform (UCV) is a unique and very special approach to cancer treatment – a better way to treat cancer.
Be Part of Something Special
We’ve made significant progress to date, and we are currently raising money to fund this valuable immunotherapy research.
Biotech is an important sector that should be in an investor's portfolio. A company like CancerVax can be an attractive addition that you should consider.
We invite you to join our mission and be part of something exciting, deeply meaningful, and the future of cancer treatment. Our investors are poised to enjoy the ride as we continue to make progress.
Use the button below to learn about our attractive CancerVax bonus share program, get important questions answered, and see how you can earn bonus shares by acting today.
This offering is made in reliance on Regulation A under the Securities Act of 1933. The securities offered are speculative, illiquid, and an investor could lose the entire investment. Investors should read the relevant Offering Circular and consider the risks disclosed therein before investing. For full disclaimers, visit https://cancervax.com/2024oc
#CancerStories